CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

uMotif to Showcase Modern eConsent and eCOA Platform to Bolster the Pivotal Patient-Site Relationship in Clinical Trials at Life Sciences Events

ConferencePositive
AI Analysis

Summary

uMotif will showcase its eConsent and eCOA platform at life sciences events, highlighting its consumer-grade technology for clinical trial participants and sites. The announcement features remarks from company leadership including CEO Andrea Valente and other executives.

Importance:2/10
Sentiment:
0.30
digital healthclinical trialseConsenteCOApatient engagement

Read the original article

Published by PR Newswire Biotech on September 10, 2026 11:00 AM

Read Original